Institution statistics

FOUNDATION BIOMEDICAL PRIMATE RESEARCH CENTRE - Netherlands 

Ranking results:

Past rankings:
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:900-1000
Total Project Funding:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:70
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:46
Project Leadership Index:75
Diversity Index:60
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding:> 1000
Total Project Funding per Partner:800-900
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2009
Criterium:Position:
Overall Score:600-700
Total Project Funding:400-500
Total Project Funding per Partner:400-500
Total Number of Projects:400-500
Networking Rank (Reputation):600-700
Partner Constancy:59
Project Leadership Index:300-400
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:> 1000
Total Project Funding:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding:> 1000
Total Project Funding per Partner:700-800
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:900-1000
Ranking timeline:

European project participation (2000-01-01 - 2019-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 42
As coordinator: 2
As participant: 38
Sole participant: 2
Coordinator / Participant Ratio: 0.05*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2017 0 10.599.993 626.814 1
2015 0 18.200.000 918.195 1
2014 0 1.234.000 6.000 1
2013 0 7.450.801 1.260.645 2
2012 0 2.959.590 444.571 1
2011 0 9.938.496 3.205.566 2
2010 0 11.996.730 778.000 1
2009 300.000 26.832.334 1.408.825 1 5
2007 0 2.345.358 390.893 1
2006 0 21.657.097 2.105.629 4
2005 0 1.884.980 471.245 2
2004 40.000 0 40.000 1
2003 0 3.165.602 452.229 1
2002 0 11.683.801 1.695.785 7
2001 583.310 1.450.000 790.453 1 1
2000 1.469.718 29.596.535 2.582.357 1 8
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE11
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE10
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD10
STICHTING KATHOLIEKE UNIVERSITEIT9
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE8
INSTITUT PASTEUR8
KAROLINSKA INSTITUTE7
STATENS SERUM INSTITUT7
DEPARTMENT OF HEALTH6
LEIDEN UNIVERSITY6
MEDICAL RESEARCH COUNCIL6
SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL6
EUROPEAN VACCINE INITIATIVE EEIG5
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE5
UNIVERSITAETSKLINIKUM HEIDELBERG5
DEUTSCHES PRIMATENZENTRUM4
HEALTH PROTECTION AGENCY4
ISTITUTO SUPERIORE DI SANITA4
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV4
MRC NATIONAL INSTITUTE FOR MEDICAL RESEARCH4
NATIONAL BIOLOGICAL STANDARDS BOARD4
STICHTING TUBERCULOSIS VACCINE INITIATIVE4
UNIVERSITE DE GENEVE4
UNIVERSITE LOUIS PASTEUR STRASBOURG 14
UNIVERSITY OF EDINBURGH4
UNIVERSITY OF GLASGOW4
ACADEMISCH ZIEKENHUIS LEIDEN3
BERNHARD NOCHT INSTITUT FUER TROPENMEDIZIN3
ETNA BIOTECH S R L3
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V3
FUNDACIO CENTRE DE RECERCA EN SALUT INTERNATIONAL DE BARCELONA3
GLAXOSMITHKLINE BIOLOGICALS3
INSTITUT PASTEUR DE LILLE3
STICHTING DIENST LANDBOUWKUNDIG ONDERZOEK3
STOCKHOLMS UNIVERSITET3
UNIVERSIDAD DE ZARAGOZA3
UNIVERSIDAD DEL VALLE3
UNIVERSITAET ZUERICH3
UNIVERSITE DE LAUSANNE3
UNIVERSITE LIBRE DE BRUXELLES3
UNIVERSITY OF COPENHAGEN3
WORLD HEALTH ORGANIZATION3
ACADEMISCH ZIEKENHUIS BIJ DE UNIVERSITEIT VAN AMSTERDAM2
ASTON UNIVERSITY2
AVENTIS PASTEUR2
BERNA BIOTECH2
COMMISSARIAT A L'ENERGIE ATOMIQUE2
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS2
CONSIGLIO NAZIONALE DELLE RICERCHE2
COVANCE LABORATORIES2
CRUCELL HOLLAND B V2
EBERHARD KARLS UNIVERSITAET TUEBINGEN2
EDUCATIONAL FOUNDATION YONSEI UNIVERSITY2
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH2
EUROPEAN MOLECULAR BIOLOGY LABORATORY2
FELTALALOI ES KUTATO KOZPONT SZOLGALTATO KFT2
FUNDACIO INSTITUT DE INVESTIGACIO EN CIENCIES DE LA SALUT GERMANS TRIAS I PUJOL2
GENOME RESEARCH2
GSFRESEARCH CENTER FOR ENVIRONMENT AND HEALTH2
HELMHOLTZZENTRUM FUER INFEKTIONSFORSCHUNG2
HOSPICES CANTONAUX CHUV2
IDLELYSTAD INSTITUUT VOOR DIERHOUDERIJ EN DIERGEZONDHEID BV2
INSTITUT SCIENTIFIQUE DE SANTE PUBLIQUE2
INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA2
INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY2
JOHANNES GUTENBERG UNIVERSITAET MAINZ2
JUSTUSLIEBIGUNIVERSITY OF GIESSEN2
KING'S COLLEGE LONDON2
MICROBIOLOGICAL RESEARCH AUTHORITY2
MINISTERIE VAN VOLKSGEZONDHEID WELZIJN EN SPORT2
POLYMUN SCIENTIFIC IMMUNBIOLOGISCHE FORSCHUNG2
PROGRAM FOR APPROPRIATE TECHNOLOGYIN HEALTH2
RUPRECHT KARLS UNIVERSITAET HEIDELBERG2
SWISS TROPICAL INSTITUTE2
THE UNIVERSITY OF EDINBURGH2
UNIVERSITA DEGLI STUDI DI BARI2
UNIVERSITA DEGLI STUDI DI PADOVA2
UNIVERSITAET BASEL2
UNIVERSITAET REGENSBURG2
UNIVERSITAET ULM2
UNIVERSITE DE MONTPELLIER II SCIENCES ET TECHNIQUES DU LANGUEDOC2
UNIVERSITE PAUL SABATIER DE TOULOUSE III2
UNIVERSITEIT GENT2
VAKZINE PROJEKT MANAGEMENT2
ACE BIOSCIENCES1
ADVANCED BIOTECHNOLOGY CENTRE1
AERAS GLOBAL TB VACCINE FOUNDATION1
AFRICAN MALARIA NETWORK TRUST1
ALBERT LUDWIGS UNIVERSITAET FREIBURG1
AMAKEM NV1
ANAXOMICS BIOTECH S L1
AUTONOMOUS UNIVERSITY OF BARCELONA1
AVARIS AB1
AZIENDA OSPEDALIERA UNIVERSITARIA POLICLINICO PAOLO GIACCONE DI PALERMO1
bangor university1
BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE1
BIOMERIEUX ALLIANCE1
BRIGHTON COLLABORATION FOUNDATION1
CANCER RESEARCH UK1
CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES1
Constancy:

Total number of partners:433

Partner loyalty:
Frequent Partner: (> 2 projects): 201
Rare Partner: 232

Frequent / Rare Partner Ratio: 0.87

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES32
RTD HORIZONTAL TOPICS30
SOCIAL AND ECONOMIC CONCERNS21
PROTECTING MAN AND HIS ENVIRON13

Project overview:

Start dateProjectacronymrolefundingpartners
2017-05-01European Vaccine Research and Development Infrastructure TRANSVAC2participant10.599.99326
2015-01-01TBVAC2020; Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development TBVAC2020participant18.200.00044
2014-01-01Use of PRIMate MOdels to support translational MEDicine and advance disease modifying therapies for unmet medical needs PRIMOMEDparticipant1.234.0006
2013-11-01Combinatorial immunization strategy to educate the immune system towards cross recognition and coverage against antigenic drift in seasonal influenza virus exposure EDUFLUVACparticipant4.647.1497
2013-01-01Identifying correlates of protection to accelerate vaccine trials: systems evaluation of two models of experimentally-induced immunity to malaria SYSMALVACparticipant2.803.6527
2012-01-01Tolerance Restoration In Autoimmune Diseases by selective manipulation of the CD28 costimulatory pathway TRIADparticipant2.959.5907
2011-02-01"West Nile Integrated Shield Project: Epidemiology, Diagnosis and Prevention of West Nile Virus in Europe" WINGSparticipant2.938.4979
2011-01-01European Primate Network: Advancing 3Rs and International Standards in Biological and Biomedical Research EUPRIM-Net IIparticipant6.999.99911
2010-01-01Discovery and preclinical development of new generation tuberculosis vaccines NEWTBVACparticipant11.996.73035
2009-11-01Platform for the Harmonization of Vaccine Adjuvant Testing PHARVATcoordinator300.0003
2009-10-01Towards the establishment of a permanent European Virtual Institute dedicated to Malaria Research (EVIMalaR) EVIMALARparticipant12.000.00039
2009-10-01European Network of Vaccine Development and Research TRANSVACparticipant9.899.99915
2009-04-01Initiative on optimizing malaria vaccine lab assays evaluation OPTIMALVACparticipant1.000.00014
2009-02-01Optimisation of the development of Poverty-Related-Diseases (PRD) vaccines by a transversal approach, addressing common gaps and challenges INYVAXparticipant932.33510
2009-02-01Signalling in life cycle stages of malaria parasites MALSIGparticipant3.000.00017
2007-01-15Pre-clinical studies towards an affordable, safe and efficacious two-component paediatric malaria vaccine PRIBOMALparticipant2.345.3586
2006-12-01The European malaria vaccine development association EMVDAparticipant13.500.00016
2006-04-01European Primate Network: specialized infrastructures and procedures for biological and biomedical research EUPRIM-NETparticipant4.769.9668
2006-02-01SME Led Malaria Vaccine Initiative SME MALARIAparticipant1.696.4054
2006-01-01Development of a novel therapeutic HIV-1 vaccine: Horizontal gene transfer by using apoptotic HIV-1 DNA containing activated T cells AUTO/ALLOCELL-HIVparticipant1.690.7267
2005-08-01Identification of novel HIV-1 epitopes as vaccine candidates EPI-VACparticipant911.0504
2005-01-01DEVELOPMENT OF A NEW VACCINE AGAINST HIV: VIROSOMES INCORPORATING HIV PROTEINS HIV VIROSOMESparticipant973.9304
2004-06-01The role of the innate immune system in microglia activation and the priming of myelin-specific autoreactive T cells MGLIADIFFcoordinator40.0001
2003-01-01Glucocorticoid hormone programming in early life and its impact on adult health EUPEAHparticipant3.165.6027
2002-11-01Improvement of a therapeutic adjuvanted protein hiv vaccine by combination with dna immunization in prime-boost regimen (HIVPRIMEBOOSTTHERVAC) HIVPRIMEBOOSTTHERVACparticipant1.062.5543
2002-11-01Research infrastructure to promote primate molecular biology INPRIMATparticipant1.675.6267
2002-11-01Genetic analysis of the chloroquine drug resistance and accelerated-resistance-to-multiple-drugs phenotype in the human malarial parasite plasmodium falciparum MALCROSSparticipant749.4495
2002-09-01Structure, function and vaccine potential of the vir multigene family in malaria VIRIMALparticipant1.196.1806
2002-09-01Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as drugs against tuberculosis (NEW ANTIMYCOBACTERIALS) NEW ANTIMYCOBACTERIAparticipant1.500.0008
2002-09-01The second phase of a european malaria vaccine development consortium EUROMALVAC-2participant3.700.04412
2002-01-01Clinical and pre-clinical evaluation of fosmidomycin and its derivates as antimalarial drugs NEW ANTIMALARIALSparticipant1.799.9487
2001-11-01Nonhuman primates as preclinical models : facility of chronic and degenerative disease in humans 'pcdd' PCDDcoordinator583.3101
2001-01-01Malarial chemotherapy targeting plasmodial phospholipid biosynthesis: implementation of a prodrug strategy for orally active compounds NOVEL ANTIMALARIALSparticipant1.450.0007
2000-10-01Development and testing of a combined anti-retroviral, immune, and gene therapy for treatment of hiv patients HIV COM THERcoordinator1.469.7187
2000-09-01Integrated system to manage the enormous complexity of the genome and proteome of the specific immune response: imgt, the international immunogenetics database. IMGTparticipant1.250.0005
2000-03-01Hepatitis c virus (hcv) : prevention and treatment of infection and disease HCVACCparticipant4.098.03015
2000-03-01Interruption of malaria transmission : vaccine strategies MALTRANSparticipant2.499.9629
2000-03-01New genetic techologies: application to generate attenuated malaria vaccines ATTMALparticipant1.492.6405
2000-02-01A european malaria vaccine development consortium: euromalvac 1 EUROMALVAC 1participant3.500.00010
2000-02-01European network for vaccine evaluation in primates: combined vector immunisations for aids vaccine development ENVEPparticipant2.995.9868
2000-02-01A cluster for tuberculosis vaccine development TB VACCINE CLUSTERparticipant4.914.91730
2000-01-01European vaccine effort against hiv/aids EUROVACparticipant8.845.00023

Alias institution names:
  • FOUNDATION BIOMEDICAL PRIMATE RESEARCH CENTRE

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum